NOVO NORDISK LTD
Novo Nordisk is a focused
healthcare company. With the broadest diabetes product
portfolio in the industry, including the most advanced
products within the area of insulin delivery systems, Novo
Nordisk is the world leader in diabetes care.
In addition, Novo Nordisk has a leading position within
areas such as GH therapy, haemostasis management and
hormone replacement therapy.
Within the area of GH, Novo Nordisk has been
producing recombinant human GH since 1988. The first,
and still the only, liquid GH in the UK was launched by Novo
Nordisk in 1999, along with an advanced delivery system. Novo Nordisk also provides the support of a homecare
service and the convenience of home delivery.
Novo Nordisk manufactures and markets pharmaceutical
products and services that make a significant difference to
patients, the medical profession and society. With headquarters
in Denmark, Novo Nordisk employs more than 26 000 people
in 80 countries and markets its products in 179 countries. For
further company information visit www.novonordisk.co.uk.
Novo Nordisk Ltd, Broadfield Park, Brighton Road, Crawley
RH11 9RT, UK
Tel: 01293-762000
http://www.novonordisk.com